{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:37:21Z","timestamp":1775918241274,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T00:00:00Z","timestamp":1395619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The incidence of human papillomavirus (<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>)\u2010associated anal cancer is increasing. Men who have sex with men (<jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content>), particularly those coinfected with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>, are disproportionately affected. Documenting the molecular epidemiology of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> infection is important in guiding policy makers in formulating universal and\/or targeted vaccine guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective cohort study was conducted. <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive and <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative <jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content> &gt;\u200918 years old were invited to participate. Provider\u2010performed anal swabs were collected and anal <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> infection was detected using consensus primer solution phase polymerase chain reaction (<jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>) followed by type\u2010specific <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> for high\u2010risk (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>)\u2010<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> types 16, 18 and 31. Between\u2010group differences were analysed using \u03c7<jats:sup>2<\/jats:sup> tests and Wilcoxon rank tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred and ninety\u2010four <jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content> [mean (standard deviation (<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>)) age 36 (10) years; 51% <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive) were recruited. The median number of sexual contacts in the preceding 12 months was 4 (interquartile range 2\u201010). <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive subjects had a mean (<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>) <jats:styled-content style=\"fixed-case\">CD4<\/jats:styled-content> count of 557 (217) cells\/\u03bcL, and 84% were on highly active antiretroviral therapy (<jats:styled-content style=\"fixed-case\">HAART<\/jats:styled-content>). Thirty\u2010one samples were <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content><\/jats:italic>\u2010globin negative and thus excluded from further analysis. A total of 113 subjects (69%) had detectable <jats:styled-content style=\"fixed-case\">HPV DNA<\/jats:styled-content>. Sixty\u2010eight subjects (42%) had an <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> type detected. <jats:styled-content style=\"fixed-case\">HR HPV<\/jats:styled-content> type 16 was detected in 44 samples (27%), <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> type 18 in 26 samples (16%) and <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> type 31 in 14 samples (23%). Twenty\u2010eight subjects (17%) had more than one type of <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> type detected. When <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> were stratified by age, those &gt;\u200935 years had a higher prevalence (<jats:italic>P<\/jats:italic>\u2009=\u20090.001 and <jats:italic>P<\/jats:italic>\u2009=\u20090.028, respectively). <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive subjects were more likely than <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010negative subjects to have any detectable <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> (77% <jats:italic>vs.<\/jats:italic> 61%, respectively; <jats:italic>P<\/jats:italic>\u2009=\u20090.04), to have <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> type 18 or 31 (<jats:italic>P<\/jats:italic>\u2009=\u20090.05 and <jats:italic>P<\/jats:italic>\u2009=\u20090.006, respectively) and to be infected with more than one <jats:styled-content style=\"fixed-case\">HR\u2010HPV<\/jats:styled-content> type (31% <jats:italic>vs.<\/jats:italic> 3%, respectively; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Within the <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive group, the prevalence of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> was higher in those not on <jats:styled-content style=\"fixed-case\">HAART<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u2009=\u20090.041), although it did not differ when stratified by <jats:styled-content style=\"fixed-case\">CD4<\/jats:styled-content> count.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The identified prevalence of anal <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> infection was high. Emerging patterns of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010related disease strengthen the call for universal vaccination of boys and girls with consideration of catch\u2010up and targeted vaccination of high\u2010risk groups such as <jats:styled-content style=\"fixed-case\">MSM<\/jats:styled-content> and those with <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12150","type":"journal-article","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T04:22:47Z","timestamp":1395634967000},"page":"499-504","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act"],"prefix":"10.1111","volume":"15","author":[{"given":"C","family":"Sadlier","sequence":"first","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Rowley","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Morley","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Surah","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"O'Dea","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Delamere","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"O'Leary","sequence":"additional","affiliation":[{"name":"Histopathology, Central Pathology Laboratory St James's Hospital\/Trinity College  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Smyth","sequence":"additional","affiliation":[{"name":"Histopathology, Central Pathology Laboratory St James's Hospital\/Trinity College  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Sheils","sequence":"additional","affiliation":[{"name":"Histopathology, Central Pathology Laboratory St James's Hospital\/Trinity College  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bergin","sequence":"additional","affiliation":[{"name":"Department of GU Medicine and Infectious Diseases (GUIDE) St James's Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,3,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.8.813"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.03.033"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs491"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.111"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-10-200805200-00005"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817aebfe"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20365"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1012"},{"key":"e_1_2_6_10_1","unstructured":"RyanM.An evaluation of the impact of highly active antiretroviral therapy on the pharmacoeconomics and pharmacoepidemiology of HIV infection. PhD thesis accepted2001. University of Dublin Trinity College."},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000233310.90484.16"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/597307"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.07.007"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3884"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70219-X"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1036"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis694"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24215"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000226963.10342.f4"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/514194"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir637"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31825d5cb8"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000140012.02703.10"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0754"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2012.11.001"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12150","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:28:49Z","timestamp":1729582129000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,24]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1111\/hiv.12150"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12150","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,24]]}}}